METAvivor
@metavivor
Funding vital MBC research, METAvivor's programs sustain the power of hope. We rally public attention to the needs of the metastatic breast cancer community.
09-03-2011 20:12:46
3,9K Tweets
6,5K Followers
820 Following
Survival Outcomes in Patients With HR+ MBC With Low or No HER2 Expression Treated With Targeted Therapies Plus Endocrine Therapy | comment: Lillie D. Shockney RN, BS, MAS, HON-ONN-CG prac.co/l/24ctrx4u via PracticeUpdate